导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 4.03% | 446/1050 |
| 近一周 | -2.11% | 722/1104 |
| 近一月 | 0.13% | 124/1103 |
| 近一季 | 5.57% | 128/1092 |
| 近半年 | -5.11% | 630/1070 |
| 近一年 | 14.15% | 315/1018 |
| 近两年 | 25.75% | 726/926 |
| 近三年 | -6.69% | 719/834 |
| 成立以来 | 88.55% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.48% 126/1070 |
-11.29% 944/1101 |
- - |
- - |
| 2025 | 0.16% 927/1065 |
4.05% 476/1014 |
-14.12% 1004/1038 |
3.65% 959/1050 |
8.15% 71/1065 |
| 2024 | -0.14% 585/1011 |
-8.56% 722/960 |
-3.60% 553/983 |
12.51% 417/991 |
0.69% 283/1011 |
| 2023 | -14.57% 504/952 |
10.65% 99/880 |
-4.23% 470/895 |
-11.54% 655/915 |
-8.86% 803/952 |
| 2022 | -26.81% 550/867 |
-16.40% 323/773 |
14.45% 134/806 |
-15.58% 598/845 |
-9.38% 772/867 |
| 2021 | -5.47% 422/740 |
-4.94% 337/580 |
7.58% 417/659 |
-5.86% 383/704 |
-1.81% 508/740 |
| 2020 | 85.83% 73/554 |
0.84% 142/419 |
26.95% 163/466 |
19.52% 61/517 |
21.46% 106/554 |
| 2019 | 43.66% 196/410 |
20.72% 903/1149 |
- 334/1231 |
9.66% 119/390 |
8.53% 219/410 |
| 2018 | -15.88% 31/349 |
- - |
- - |
- - |
-15.48% 892/1080 |
| 2017 | 24.88% 64/285 |
- - |
- - |
- - |
- - |
| 2016 | -15.03% 93/205 |
- - |
- - |
- - |
- - |
| 2015 | 19.90% 54/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 民生加银优选股票 VS. 东吴新产业精选股票A(580008) |